Page last updated: 2024-08-24

gemcitabine and Chromosome-Defective Micronuclei

gemcitabine has been researched along with Chromosome-Defective Micronuclei in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boccia, R; Buresti, G; Carbonari, D; Cavallo, D; Chiarella, P; Ciervo, A; Colosio, C; Delrio, P; Fresegna, AM; Iavicoli, S; Jemos, C; Maiello, R; Maiolino, P; Mandić-Rajčević, S; Marchetti, P; Omodeo Salè, E; Rubino, FM; Ursini, CL	1
Bai, J; Fu, S; Guan, R; Huang, Y; Ji, W; Jin, Y; Meng, X; Quan, C; Sun, D; Sun, W; Yu, L; Yu, Y; Zhang, C; Zhao, Y; Zhu, J	1

Other Studies

2 other study(ies) available for gemcitabine and Chromosome-Defective Micronuclei

Article	Year
Antineoplastic drug occupational exposure: a new integrated approach to evaluate exposure and early genotoxic and cytotoxic effects by no-invasive Buccal Micronucleus Cytome Assay biomarker. Toxicology letters, 2019, Volume: 316 Topics: Adult; Antineoplastic Agents; Biomarkers; Case-Control Studies; Deoxycytidine; DNA Glycosylases; Environmental Monitoring; Female; Fluorouracil; Gemcitabine; Humans; Italy; Male; Micronuclei, Chromosome-Defective; Micronucleus Tests; Middle Aged; Mouth Mucosa; Nursing Staff, Hospital; Occupational Exposure; Occupational Health; Oncology Nursing; Polymorphism, Genetic; Risk Assessment; Risk Factors; Urinalysis; X-ray Repair Cross Complementing Protein 1	2019
Gemcitabine eliminates double minute chromosomes from human ovarian cancer cells. PloS one, 2013, Volume: 8, Issue:8 Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; DNA Damage; DNA, Neoplasm; Eukaryotic Translation Initiation Factor 5A; Female; Gemcitabine; Gene Amplification; Histones; Humans; Hydroxyurea; In Situ Hybridization, Fluorescence; Micronuclei, Chromosome-Defective; Myeloid Cell Leukemia Sequence 1 Protein; N-Myc Proto-Oncogene Protein; Nuclear Proteins; Oncogene Proteins; Ovarian Neoplasms; Peptide Initiation Factors; Real-Time Polymerase Chain Reaction; RNA-Binding Proteins	2013

Article

Year

Antineoplastic drug occupational exposure: a new integrated approach to evaluate exposure and early genotoxic and cytotoxic effects by no-invasive Buccal Micronucleus Cytome Assay biomarker.

Toxicology letters, 2019, Volume: 316

Topics: Adult; Antineoplastic Agents; Biomarkers; Case-Control Studies; Deoxycytidine; DNA Glycosylases; Environmental Monitoring; Female; Fluorouracil; Gemcitabine; Humans; Italy; Male; Micronuclei, Chromosome-Defective; Micronucleus Tests; Middle Aged; Mouth Mucosa; Nursing Staff, Hospital; Occupational Exposure; Occupational Health; Oncology Nursing; Polymorphism, Genetic; Risk Assessment; Risk Factors; Urinalysis; X-ray Repair Cross Complementing Protein 1

2019

Gemcitabine eliminates double minute chromosomes from human ovarian cancer cells.

PloS one, 2013, Volume: 8, Issue:8

Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; DNA Damage; DNA, Neoplasm; Eukaryotic Translation Initiation Factor 5A; Female; Gemcitabine; Gene Amplification; Histones; Humans; Hydroxyurea; In Situ Hybridization, Fluorescence; Micronuclei, Chromosome-Defective; Myeloid Cell Leukemia Sequence 1 Protein; N-Myc Proto-Oncogene Protein; Nuclear Proteins; Oncogene Proteins; Ovarian Neoplasms; Peptide Initiation Factors; Real-Time Polymerase Chain Reaction; RNA-Binding Proteins

2013